X Agirre, A Fontalba, EJ Andreu, MD Odero, MJ Larrayoz, C Montiel, MJ Calasanz, JL Fernandez-Luna, F Prosper. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. haematol [Internet]. 2003Dec.1 [cited 2024Apr.20];88(12):1425-6. Available from: https://haematologica.org/article/view/2924